Robots and dyes could spare testicular cancer patients unnecessary treatment
NCT ID NCT06133543
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 32 times
Summary
This study tests a new, robot-assisted technique to see if testicular cancer has spread to nearby lymph nodes. Doctors inject a green dye into the testicle, then use a robot with a special camera to find and remove the first lymph node that drains the tumor. The goal is to improve accuracy and reduce overtreatment. The trial will enroll 44 adults with early-stage testicular cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GERM CELL TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital of Duesseldorf
RECRUITINGDüsseldorf, Germany
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
indocyanine green (ICG) dye
What this could lead to
If successful, this could replace standard staging with a more precise, minimally invasive procedure, reducing unnecessary treatments and side effects.
What could go wrong
This is a small, early feasibility study (44 participants) with no control group. The technique may not achieve the desired 90% sensitivity or may have complications like retrograde ejaculation.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.